Tag: hepatocellular carcinoma
1. Transarterial chemoembolization (TACE) was shown to have survival and treatment response rates comparable to both hepatic resection (HR) and radiofrequency ablation (RFA) in the management of small, focal hepatocellular carcinomas (HCC).
2. TACE was shown to be associated with a higher HCC recurrence rate relative to HR and RFA.
Evidence...
Image: PD
1. In patients with hepatocellular carcinoma who underwent liver transplantation, response to transarterial chemoembolization and radiologic size of tumor were both shown to independently predict rates of recurrence.
2. Patients with no response to chemoembolization and a radiologic tumor size greater than 3 cm had a recurrence rate of...
Image: PD
1. The risk of hepatocellular carcinoma recurrence increased with high levels of hepatitis B surface antigen (HBsAg), specifically at HBsAg above 1000 IU/mL.
2. Both 5-year disease-free survival and overall survival was lower in patients with high HBsAg levels, despite low viral loads.
Evidence Rating Level: 2 (Good)
Study Rundown: Partial...
Image: PD
1. Patients at high risk for hepatocellular carcinoma who underwent biannual screening with serum AFP levels and liver ultrasound were much more likely to be diagnosed with cancer in the earlier stages and receive curative treatment.
2. Biannual screening for hepatocellular carcinoma leads to a significant reduction in 5-year...
Image: PD
1. Liver failure was more frequent in post-hepatectomy patients with HBV reactivation, resulting in shorter 3-year disease-free survival and overall survival.
2. Prophylactic antiviral treatment is protective against HBV reactivation.
Routine prophylactic antiviral treatment should be used for patients with hepatocellular carcinoma associated with Hepatitis B. If administered prior...